昆药集团(600422.SH)发布半年度业绩，归母净利润1.98亿元，同比下降26.88%

Group 1 - The company reported a revenue of 3.351 billion yuan for the first half of 2025, representing a year-on-year decrease of 11.68% [1] - The net profit attributable to shareholders of the listed company was 198 million yuan, down 26.88% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 151 million yuan, a year-on-year decline of 5.57% [1] - The basic earnings per share were 0.26 yuan [1]